Abstract
In five years, Kalorama Information believes the role of pharmacists currently
and the demands of the US healthcare system, pharmacists will be prescribing
in at least six states in five years, creating a trend that will spread to
many other states in following years. The state of Florida allows some
independing prescribing off an approved list, and many states allow
prescription choice from a physicians diagnosis. The cost of copays and the
time spent on doctor visits will increase demand for drug decisions to be made
at the pharmacist level.
This report, Prescribing Pharmacists, a Decision Maker Emerges details the
reasons behind this change and defines the roles of the new decision makers
that pharmaceutical companies will have to incorporate into strategy. In the
U.S. healthcare market the role of the pharmacist is changing. This report
details the tremendous transformation occuring.
As this report details, pharmacists already have a huge impact on drug
revenues, and companies that do not develop a marketing strategy involving
this important decision maker will lose advantage in the coming years.
Pharmacists are moving from their role dispensing medications based on
phsyician instructions, to prescribing based on physician diagnosis, to
independent prescribing in some limited situations.
- The States Most Likely to allow independent prescription in five
years, and what states will follow.
- The amount of drug revenues currently influenced by pharmacists,
and forecasts to 2012.
- The therapeutic areas most likely to see pharmacist influence.
- Main drivers of the prescribing pharmacist trend.
- Overview of state of Florida and Federal programs that already allow
pharmacist prescription authority.
- Useful background on the populations of pharmacists by area, their
training pharmacists, and their role in drug purchases
- Details on drug interactions and pharmacist role in reducing
prescription errors
- Extensive statistics on the U.S. health insurance trends that are driving
prescribing trends
- Review of cooperative therapy management programs already allowing
pharmacists some prescriptive authority and how they operate in 43 states
- Review of international pharmacy programs that allow prescriptive
authority
This report is essential reading for anyone seeking to develop a marketing
plan that addresses the increasing influence of pharmacists, and to be aware
of and ready for their increasing direct control over prescriptions.
Kalorama' s methodology involves a thorough search of government and company
literature; but true insights come from interviews with company executives,
members of state pharmacy boards, pharmacists and physicians. Over 200 of
these individuals were interviewed for this report.
Marketing and business development directors in the pharmaceutical industry,
as well as financial companies looking at broad trends in healthcare are among
those who will benefit from this report.
| 
View Cart
